Literature DB >> 10672935

LFA-1- and ICAM-1-dependent homotypic aggregation of human thymocytes induced by JL1 engagement.

G K Lee1, K C Jung, W S Park, M C Kook, C S Park, H W Sohn, Y M Bae, H G Song, S H Park.   

Abstract

Cell-cell adhesion is essential for the appropriate immune response, differentiation, and migration of lymphocytes. This important physiological event is reflected in vitro by homotypic cell aggregation. We have previously reported that a 120 kDa cell surface glycoprotein, JL1, is a unique protein specifically expressed by immature double positive (DP) human thymocytes which are in the process of positive and negative selections through the interaction between thymocyte and antigen-presenting cells (APCs). The function of the JL1 molecule, however, is yet to be identified. We show here that anti-JL1 monoclonal antibody (mAb) induced the homotypic aggregation of human thymocytes in a temperature- and Mg2+-dependent manner. It required an intact cytoskeleton and the interaction between leucocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) since it was blocked by cytochalasin B and D, and mAb against LFA-1 and ICAM-1 which are known to be involved in the aggregation of thymocytes. Translocation of phosphatidylserine (PtdSer) through the cell membrane was not detected, implying that the molecular mechanism of JL-1-induced homotypic aggregation is different from that of CD99-induced homotypic aggregation. In summary, JL1 is a cell surface molecule that induces homotypic adhesion mediated by the LFA-1 and ICAM-1 interaction and cytoskeletal reorganization. These findings suggest that JL1 may be an important regulator of thymocyte development and thymocyte-APC interaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10672935

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  2 in total

1.  Expression of JL1 in Burkitt lymphoma is associated with improved overall survival.

Authors:  Ilseon Hwang; Heounjeong Go; Yoon Kyung Jeon; Young Hyeh Ko; Dok Hyun Yoon; Cheolwon Suh; Joo Ryung Huh; Hyangsin Lee; Minchan Gil; Chan-Sik Park
Journal:  Virchows Arch       Date:  2011-08-04       Impact factor: 4.064

2.  JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma.

Authors:  Min Sun Kim; Chan Jeoung Park; Young Uk Cho; Seongsoo Jang; Eul Ju Seo; Chan Sik Park; Jooryung Huh; Ho Joon Im; Jong Jin Seo; Dok Hyun Yoon; Cheolwon Suh
Journal:  Ann Lab Med       Date:  2020-01       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.